July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Evaluation of patients with Stargardt disease by Microperimetry and Fundus Autofluorescence: identification of a new biomarker in defining the natural history of disease
Author Affiliations & Notes
  • Valentina Di lorio
    Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
  • Ada Orrico
    Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
  • Raffaella Brunetti-Pierri
    Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
  • Mariaelena Filippelli
    Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
  • Paolo Melillo
    Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
  • Anna Nesti
    Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
  • Settimio Rossi
    Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
  • Alberto Auricchio
    Telethon Institute of Genetics and Medicine,, Pozzuoli, Italy
    Department of Advanced Biomedicine, University of Naples Federico II, Naples, Italy
  • Francesca Simonelli
    Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
  • Francesco Testa
    Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
  • Footnotes
    Commercial Relationships   Valentina Di lorio, None; Ada Orrico, None; Raffaella Brunetti-Pierri, None; Mariaelena Filippelli, None; Paolo Melillo, Sanofi (R); Anna Nesti, None; Settimio Rossi, None; Alberto Auricchio, None; Francesca Simonelli, Sanofi (R); Francesco Testa, Sanofi (R)
  • Footnotes
    Support  Fondazione Telethon
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 5036. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Valentina Di lorio, Ada Orrico, Raffaella Brunetti-Pierri, Mariaelena Filippelli, Paolo Melillo, Anna Nesti, Settimio Rossi, Alberto Auricchio, Francesca Simonelli, Francesco Testa; Evaluation of patients with Stargardt disease by Microperimetry and Fundus Autofluorescence: identification of a new biomarker in defining the natural history of disease. Invest. Ophthalmol. Vis. Sci. 2019;60(9):5036.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We evaluated the progression of Stargardt disease due to ABCA4 mutations (STGD1) using Microperimetry (MP1) and Fundus Autofluorescence (FAF) imaging in order to investigate their capability to detect macular degeneration over a short-term follow-up (1 year).

Methods : We analyzed data from 57 patients with a clinical and molecular diagnosis of STGD1 (mean age: 33.5±1.8 years; mean disease duration: 13.4±1.3 years), undergoing a baseline and a follow-up visit, including best corrected visual acuity (BCVA), fundus examination, electroretinogram (ERG), FAF and MP1. Fundus and ERG were classified as shown in Fig. 1. To estimate disease progression, we evaluated definitely decreased autofluorescence (DDAF) from FAF images and absolute scotoma area from MP1. The study, approved by the Local Ethics Committee, adhered to the Declaration of Helsinki and each patient gave written informed consent.

Results : BCVA was 0.67±0.06 LogMAR. Fundus lesions were consistent with Fishman I phenotype in 22 patients (38.6%), with Fishman II phenotype in 17 patients (29.8%), and with Fishman III phenotype in 18 patients (31.6%). ERG responses were: Lois I in 29 patients (50.9%), Lois II in 24 patients (42.1%), and Lois III in 4 patients (7.0%). Absolute scotoma area was 5.54 ± 1.19 mm2, whereas DDAF was 2.78 ± 0.44 mm2. Actually, the absolute scotoma area was significantly greater than the DDAF (p = 0.009). Moreover, we observed a significant (p-value<0,001) correlation of the absolute scotoma area and of DDAF with age and duration of the disease, but not with the age of disease onset. Patients with Fishman III had significantly higher values of DDAF compared to the Fishman I phenotype and patients with Lois III presented areas of absolute scotoma significantly larger than the Lois group I. Finally, the longitudinal analysis showed that absolute scotoma area increased more quickly compared to DDAF (absolute scotoma: 1.41 mm2 / year vs DDAF: 0.20 mm2/year).

Conclusions : The observation of a wider absolute scotoma area compared to DDAF at baseline and its faster progression suggest that a significant loss in photoreceptor function occurs before the death of retinal pigmented epithelium cells. This study shows that MP1 could be a sensible examination to evaluate retinal degeneration in STGD1 and consequently the effect of experimental treatments.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×